Simon Nicholas J Iii - Net Worth and Insider Trading

Simon Nicholas J Iii Net Worth

The estimated net worth of Simon Nicholas J Iii is at least $0 dollars as of 2025-07-24. Simon Nicholas J Iii is the Director of Rigel Pharmaceuticals Inc and owns about 0 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $0. Details can be seen in Simon Nicholas J Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Simon Nicholas J Iii has not made any transactions after 2004-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Simon Nicholas J Iii

Simon Nicholas J Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Simon Nicholas J Iii owns 10 companies in total, including Radius Health Inc (RDUS) , Humanigen Inc (HGENQ) , and EPIRUS Biopharmaceuticals Inc (EPRSQ) among others .

Click here to see the complete history of Simon Nicholas J Iii’s form 4 insider trades.

Insider Ownership Summary of Simon Nicholas J Iii

Ticker	Company	Transaction Date	Type of Owner
RDUS	Radius Health Inc	2011-05-17	10 percent owner
HGENQ	Humanigen Inc	2012-08-11	10 percent owner
EPRSQ	EPIRUS Biopharmaceuticals Inc	2011-10-27	10 percent owner
		2010-12-14	other: Former 10% Owner
		2007-08-03	other: See explanation below
		2010-09-30	director & 10 percent owner
		2010-06-09	director & 10 percent owner
		2006-12-19	10 percent owner
		2004-11-23	director & 10 percent owner
		2003-11-04	director

Simon Nicholas J Iii Latest Holdings Summary

Simon Nicholas J Iii currently owns a total of 1 stock. Simon Nicholas J Iii owns 0 shares of Rigel Pharmaceuticals Inc (RIGL) as of November 23, 2004, with a value of $0.

Latest Holdings of Simon Nicholas J Iii

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RIGL	Rigel Pharmaceuticals Inc	2004-11-23	0	21.07	0

Holding Weightings of Simon Nicholas J Iii

Simon Nicholas J Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Simon Nicholas J Iii has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 86,806 shares on November 23, 2004, which brought Simon Nicholas J Iii around $20 Million.

Insider Trading History of Simon Nicholas J Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Simon Nicholas J Iii Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Simon Nicholas J Iii Ownership Network

Ownership Network List of Simon Nicholas J Iii

No Data

Ownership Network Relation of Simon Nicholas J Iii

Simon Nicholas J Iii Owned Company Details

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Simon Nicholas J Iii is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Simon Nicholas J Iii is the 10 percent owner of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

Simon Nicholas J Iii is the 10 percent owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Simon Nicholas J Iii is the other: Former 10% Owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Simon Nicholas J Iii is the other: See explanation below of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Simon Nicholas J Iii made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 16,011 shares made by David Drutz , a net purchase of 10,000 shares made by Gregory L Weaver , and a net purchase of 1,000 shares made by Catherine A. Sohn .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 11,000 shares were bought by its insiders, resulting in a net sale of 5,011 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Simon Nicholas J Iii is the director & 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Poniard Pharmaceuticals Inc do?

Who are the key executives at Poniard Pharmaceuticals Inc?

Simon Nicholas J Iii is the director & 10 percent owner of Poniard Pharmaceuticals Inc. Other key executives at Poniard Pharmaceuticals Inc include President & CMO Michael S Perry , director & Chief Executive Officer Ron Martell , and Chief Financial Officer Gregory L Weaver .

Poniard Pharmaceuticals Inc (PARD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poniard Pharmaceuticals Inc (PARD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poniard Pharmaceuticals Inc (PARD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poniard Pharmaceuticals Inc (PARD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Poniard Pharmaceuticals Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Simon Nicholas J Iii is the 10 percent owner of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Simon Nicholas J Iii is the director & 10 percent owner of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & GC & Corp Sec Raymond J. Furey .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Simon Nicholas J Iii made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 62,246 shares made by Raul R Rodriguez , a net sale of 18,440 shares made by David A Santos , and a net sale of 16,398 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 27,834 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,834 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Genitope Corp do?

Who are the key executives at Genitope Corp?

Simon Nicholas J Iii is the director of Genitope Corp. Other key executives at Genitope Corp include other: Former 10% Owner Cpmg Inc , Controller/Principl Acctg Off Gregory L Overholtzer , and 10 percent owner Rose Edward R Iii .

Genitope Corp (GTOPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genitope Corp (GTOPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genitope Corp (GTOPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genitope Corp (GTOPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genitope Corp Insider Transactions

No Available Data

Simon Nicholas J Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Simon Nicholas J Iii. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Simon Nicholas J Iii's mailing address is: Boston Ma 02116.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.